Submission of Confirmation of Appointment as Director.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has confirmed the appointment of Ms. Sridevi Belide (DIN: 10455373) as a Non-Executive Non-Independent Director. The appointment was approved by shareholders at an Extra-Ordinary General Meeting held on 9th January 2026, with an effective appointment date of 23rd October 2025. Ms. Belide is part of the company's promoter group and is not related to any existing director on the board. She has not been debarred from holding a director's office by SEBI or any other authority.
This is a routine board composition update involving a promoter-group member and is unlikely to have a material impact on the stock price. Investors may note continued promoter involvement in the board, but no operational or strategic change is signaled.